INTELLIGENT BIO SOLUTIONS INC. Deferred Costs, Current
INTELLIGENT BIO SOLUTIONS INC. (INBS) had Deferred Costs, Current of $67.16 thousand as of 2025-06-30, per its 10-K filed 2025-08-15.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:DeferredCostsCurrent · last filed 2025-08-15
- 2025-06-30: Deferred Costs, Current $67.16K.
- 2023-06-30: Deferred Costs, Current $34.10K.
- 2022-09-30: Deferred Costs, Current $300.00K.
- 2020-06-30: Deferred Costs, Current $1.86M.
| Period end | Deferred Costs, Current |
|---|---|
| 2025-06-30 | $67.16K 10-K · filed 2025-08-15 |
| 2023-06-30 | $34.10K 10-K · filed 2024-09-18 |
| 2022-09-30 | $300.00K 10-Q · filed 2022-11-14 |
| 2020-06-30 | $1.86M 10-K · filed 2021-09-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |